CML exposure markedly increased Bax expression and decreased Bcl-2 expression (p < 0.001 vs. control), resulting in a reduced Bcl-2/Bax ratio. Here, BCL2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.